I Choose BOTOX Cosmetic: Recent Episodes
Modern Aesthetics
Find out why experts in the medical aesthetics industry choose BOTOX® Cosmetic—for their patients AND themselves.
Twenty years ago, BOTOX® Cosmetic was FDA approved for temporary improvement in the appearance of moderate to severe frown lines in adults, making it the first product of its kind to enter the market.1,2 Looking back on the 20-year journey, the brand is celebrating all of the people, including employees, partners, providers, and loyal patients, who have made BOTOX® Cosmetic what it is today. Listen as Dr. Sara Sangha, Associate Vice President of Medical Affairs at Allergan Aesthetics, speaks with Dr. Jean Carruthers, Ophthalmologist and Cosmetic Surgeon, about the past, present, and future of BOTOX® Cosmetic, and their personal experiences with the brand. Please see BOTOX® Cosmetic full Product Information including Boxed Warning and Medication Guide. Please see additional important safety information below. *Based on an online survey of 243 neurotoxin users. Patients were asked if they ever requested to receive a specific brand of neurotoxin, and if so, which brand. Patients who received BOTOX® Cosmetic at their most recent treatment (n = 204) were asked how likely they were to continue using BOTOX® Cosmetic. Patients who were treated with BOTOX® Cosmetic (n = 204) were asked how likely they were to recommend BOTOX® Cosmetic.